FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023806495> ?p ?o ?g. }

• W2023806495 endingPage "390" @default.
• W2023806495 startingPage "386" @default.
• W2023806495 abstract "The acyclic analogue of guanosine acyclovir (ACV) constitutes the first-line drug for the treatment of herpes simplex virus (HSV) infections. ACV activation requires primophosphorylation by virus-encoded HSV thymidine kinase (TK). In 95% of cases, HSV resistance to ACV is associated with mutations located in TK. The aim of this work was to address the question of the potential involvement of novel HSV-1 and HSV-2 TK mutations in reduced susceptibility to ACV using a novel nonradioactive method, based on luminescent quantitation of ADP, for the evaluation of in vitro phosphorylation activity of TK. All recombinant TKs tested exhibited significantly lower ACV phosphorylation activities in comparison with those of reference KOS or gHSV-2 TKs (p<0.015), therefore indicating that amino acid changes Y53D, L170P, R176W, A207P (HSV-1) and S66P, A72S, I101S, M183I (HSV-2) were likely to be involved in HSV resistance to ACV." @default.
• W2023806495 created "2016-06-24" @default.
• W2023806495 creator A5002206943 @default.
• W2023806495 creator A5028342549 @default.
• W2023806495 creator A5053522439 @default.
• W2023806495 creator A5081391161 @default.
• W2023806495 creator A5084209829 @default.
• W2023806495 date "2012-12-01" @default.
• W2023806495 modified "2023-10-16" @default.
• W2023806495 title "Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity" @default.
• W2023806495 cites W1584935191 @default.
• W2023806495 cites W1770249567 @default.
• W2023806495 cites W1971727083 @default.
• W2023806495 cites W1976409125 @default.
• W2023806495 cites W1990570294 @default.
• W2023806495 cites W1998909555 @default.
• W2023806495 cites W2005966253 @default.
• W2023806495 cites W2010281033 @default.
• W2023806495 cites W2018863083 @default.
• W2023806495 cites W2026396393 @default.
• W2023806495 cites W2031044314 @default.
• W2023806495 cites W2033042244 @default.
• W2023806495 cites W2043841254 @default.
• W2023806495 cites W2047264702 @default.
• W2023806495 cites W2065088720 @default.
• W2023806495 cites W2074051138 @default.
• W2023806495 cites W2087950464 @default.
• W2023806495 cites W2088194309 @default.
• W2023806495 cites W2089824168 @default.
• W2023806495 cites W2112847184 @default.
• W2023806495 cites W2113417823 @default.
• W2023806495 cites W2114066593 @default.
• W2023806495 cites W2114922450 @default.
• W2023806495 cites W2143181082 @default.
• W2023806495 cites W2152809429 @default.
• W2023806495 cites W2157450899 @default.
• W2023806495 cites W2166775938 @default.
• W2023806495 cites W2338148689 @default.
• W2023806495 doi "https://doi.org/10.1016/j.antiviral.2012.09.016" @default.
• W2023806495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23041200" @default.
• W2023806495 hasPublicationYear "2012" @default.
• W2023806495 type Work @default.
• W2023806495 sameAs 2023806495 @default.
• W2023806495 citedByCount "29" @default.
• W2023806495 countsByYear W20238064952013 @default.
• W2023806495 countsByYear W20238064952014 @default.
• W2023806495 countsByYear W20238064952015 @default.
• W2023806495 countsByYear W20238064952016 @default.
• W2023806495 countsByYear W20238064952017 @default.
• W2023806495 countsByYear W20238064952018 @default.
• W2023806495 countsByYear W20238064952021 @default.
• W2023806495 countsByYear W20238064952022 @default.
• W2023806495 countsByYear W20238064952023 @default.
• W2023806495 crossrefType "journal-article" @default.
• W2023806495 hasAuthorship W2023806495A5002206943 @default.
• W2023806495 hasAuthorship W2023806495A5028342549 @default.
• W2023806495 hasAuthorship W2023806495A5053522439 @default.
• W2023806495 hasAuthorship W2023806495A5081391161 @default.
• W2023806495 hasAuthorship W2023806495A5084209829 @default.
• W2023806495 hasConcept C104317684 @default.
• W2023806495 hasConcept C11960822 @default.
• W2023806495 hasConcept C153911025 @default.
• W2023806495 hasConcept C159047783 @default.
• W2023806495 hasConcept C184235292 @default.
• W2023806495 hasConcept C185592680 @default.
• W2023806495 hasConcept C202751555 @default.
• W2023806495 hasConcept C2522874641 @default.
• W2023806495 hasConcept C2776147627 @default.
• W2023806495 hasConcept C2776409557 @default.
• W2023806495 hasConcept C2777108182 @default.
• W2023806495 hasConcept C2777995097 @default.
• W2023806495 hasConcept C2779450786 @default.
• W2023806495 hasConcept C2780727368 @default.
• W2023806495 hasConcept C2781196997 @default.
• W2023806495 hasConcept C36372059 @default.
• W2023806495 hasConcept C40767141 @default.
• W2023806495 hasConcept C55493867 @default.
• W2023806495 hasConcept C86803240 @default.
• W2023806495 hasConceptScore W2023806495C104317684 @default.
• W2023806495 hasConceptScore W2023806495C11960822 @default.
• W2023806495 hasConceptScore W2023806495C153911025 @default.
• W2023806495 hasConceptScore W2023806495C159047783 @default.
• W2023806495 hasConceptScore W2023806495C184235292 @default.
• W2023806495 hasConceptScore W2023806495C185592680 @default.
• W2023806495 hasConceptScore W2023806495C202751555 @default.
• W2023806495 hasConceptScore W2023806495C2522874641 @default.
• W2023806495 hasConceptScore W2023806495C2776147627 @default.
• W2023806495 hasConceptScore W2023806495C2776409557 @default.
• W2023806495 hasConceptScore W2023806495C2777108182 @default.
• W2023806495 hasConceptScore W2023806495C2777995097 @default.
• W2023806495 hasConceptScore W2023806495C2779450786 @default.
• W2023806495 hasConceptScore W2023806495C2780727368 @default.
• W2023806495 hasConceptScore W2023806495C2781196997 @default.
• W2023806495 hasConceptScore W2023806495C36372059 @default.
• W2023806495 hasConceptScore W2023806495C40767141 @default.
• W2023806495 hasConceptScore W2023806495C55493867 @default.
• W2023806495 hasConceptScore W2023806495C86803240 @default.
• W2023806495 hasIssue "3" @default.

• next